azomycin has been researched along with Metastase in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (20.00) | 29.6817 |
2010's | 4 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atkins, GJ; DeNichilo, M; Evdokiou, A; Findlay, DM; Hay, S; Ingman, W; Labrinidis, A; Liapis, V; Panagopoulos, V; Ponomarev, V; Zannettino, ACW; Zinonos, I | 1 |
Dhani, NC; Green, D; Hedley, DW; Jaffray, D; Metran-Nascente, C; Metser, U; Milosevic, M; Vines, DC; Yeung, I | 1 |
Ali, M; Babur, M; Bloomer, WD; Cawthorne, C; Julyan, PJ; Lunt, SJ; Papadopoulou, MV; Price, PM; Smigova, A; Stratford, IJ; Telfer, BA; Williams, KJ | 1 |
Cooper, ME; Gjertsen, BT; Haug, BE; Lorens, JB; McCormack, E; Micklem, DR; Pavlin, T; Silden, E; West, RM | 1 |
Evans, SM; Koch, CJ | 1 |
Fitzmaurice, RJ; Lunt, SJ; Stratford, IJ; Telfer, BA; Williams, KJ | 1 |
Anderson, PJ; Bennett, MH; Dische, S; Saunders, MI | 1 |
Phillips, TL; Stetz, J; Wasserman, TH | 1 |
Lehnert, S | 1 |
Hori, H; Inayama, S; Inomata, T; Kasai, S; Kuwasaka, H; Masui, M; Nagasawa, H; Oka, S; Oshodani, T; Uto, Y; Yamashita, M | 1 |
Dawen, PJ; Peckham, MJ; Steel, GG | 1 |
Denekamp, J | 1 |
Bleehen, NM; Plowman, PN; Wiltshire, CR; Workman, P | 1 |
Adams, GE; Dische, S; Flockhart, IR; Foster, JL; Gray, AJ | 1 |
Dische, S; Errington, LM; Gray, AJ; Thomlinson, RH | 1 |
Hill, SA; Sheldon, PW | 2 |
Adams, GE; Denekamp, J; Fowler, JF | 1 |
McNally, NJ | 1 |
Chapman, JD; Kanclerz, A | 1 |
1 review(s) available for azomycin and Metastase
Article | Year |
---|---|
Prognostic significance of tumor oxygenation in humans.
Topics: Animals; Biomarkers; Case Management; Cell Hypoxia; Energy Metabolism; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Nitroimidazoles; Oximetry; Oxygen; Oxygen Consumption; Partial Pressure; Prognosis; Radiopharmaceuticals; Rodentia; Tomography, Emission-Computed | 2003 |
3 trial(s) available for azomycin and Metastase
Article | Year |
---|---|
Primary tumor control after radiotherapy for carcinoma of the bronchus.
Topics: Bronchial Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Double-Blind Method; Humans; Misonidazole; Neoplasm Metastasis; Nitroimidazoles; Radiation Tolerance | 1984 |
Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations.
Topics: Adult; Aged; Biopsy; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Humans; Middle Aged; Nausea; Neoplasm Metastasis; Nervous System Diseases; Neurologic Examination; Nitroimidazoles; Radiation-Sensitizing Agents; Radiography; Sarcoma; Skull; Taste; Vomiting | 1976 |
Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours.
Topics: Adult; Cell Survival; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nitroimidazoles; Radiation-Sensitizing Agents; Radiotherapy Dosage; Skin Neoplasms; Soft Tissue Neoplasms | 1976 |
16 other study(ies) available for azomycin and Metastase
Article | Year |
---|---|
Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma.
Topics: Animals; Apoptosis; Bone Neoplasms; Cell Hypoxia; Female; Humans; Mice; Mice, Nude; Neoplasm Metastasis; Nitroimidazoles; Osteosarcoma; Phosphoramide Mustards; Prodrugs | 2015 |
Measurement of Tumor Hypoxia in Patients with Advanced Pancreatic Cancer Based on 18F-Fluoroazomyin Arabinoside Uptake.
Topics: Aged; Aged, 80 and over; Algorithms; Female; Humans; Hypoxia; Male; Middle Aged; Models, Biological; Neoplasm Metastasis; Nitroimidazoles; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Regional Blood Flow | 2016 |
The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Cell Line, Tumor; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation, Preclinical; Imidazoles; Lung Neoplasms; Mice; Mice, Inbred C3H; Neoplasm Metastasis; Nitroimidazoles; Quinolines; Sarcoma; Tirapazamine; Triazines | 2010 |
Nitroreductase, a near-infrared reporter platform for in vivo time-domain optical imaging of metastatic cancer.
Topics: Animals; Anti-Infective Agents; Carbocyanines; Cell Line, Tumor; Cell Survival; Escherichia coli Proteins; Green Fluorescent Proteins; HEK293 Cells; Humans; Luciferases; Magnetic Resonance Imaging; Metronidazole; Mice; Mice, Inbred NOD; Mice, SCID; Microscopy, Fluorescence; Neoplasm Metastasis; Neoplasms; Nitroimidazoles; Nitroreductases; Reproducibility of Results; Transfection; Xenograft Model Antitumor Assays | 2013 |
Tirapazamine administered as a neoadjuvant to radiotherapy reduces metastatic dissemination.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Combined Modality Therapy; Female; Hypoxia; Mice; Mice, Inbred C3H; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; Tirapazamine; Treatment Outcome; Triazines | 2005 |
Clinical trials of misonidazole in the United States.
Topics: Drug Evaluation; Head and Neck Neoplasms; Humans; Misonidazole; Neoplasm Metastasis; Neoplasms; Nervous System Diseases; Nitroimidazoles | 1981 |
Prediction of tumor response to therapy: molecular markers and the microenvironment. Apoptosis and chips: an overview of the proceedings.
Topics: Apoptosis; Biomarkers, Tumor; Biopsy; Cell Cycle; Cell Hypoxia; Cell Survival; Comet Assay; DNA Ligases; Enzyme Activation; Genes, ras; Humans; Immunohistochemistry; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms; Nitroimidazoles; Oligonucleotide Array Sequence Analysis; Predictive Value of Tests; Radiation Tolerance; Radiotherapy Dosage; Tumor Cells, Cultured | 2000 |
New antimetastatic hypoxic cell radiosensitizers: design, synthesis, and biological activities of 2-nitroimidazole-acetamide, TX-1877, and its analogues.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Movement; Drug Design; Electrochemistry; Female; Hypoxia; Leukocytes, Mononuclear; Lung Neoplasms; Macrophages; Mice; Mice, Inbred C3H; Models, Molecular; Neoplasm Metastasis; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Structure-Activity Relationship; Tumor Cells, Cultured | 2001 |
The response of human tumour metastases to radiation and misonidazole.
Topics: Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Nitroimidazoles; Radiation-Sensitizing Agents; Skin Neoplasms | 1978 |
Cytotoxicity and radiosensitization in mouse and man.
Topics: Animals; Cell Survival; Humans; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Skin Neoplasms | 1978 |
Monitoring salivary misonidazole in man: a possible alternative to plasma monitoring.
Topics: Adult; Aged; Bronchial Neoplasms; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Misonidazole; Neoplasm Metastasis; Neoplasms; Nitroimidazoles; Saliva; Skin Neoplasms | 1978 |
Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice.
Topics: Animals; Hypoxia; Metronidazole; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Nitrofurans; Nitroimidazoles; Radiation-Sensitizing Agents; Radiotherapy Dosage; Razoxane; Regeneration; Transplantation, Homologous | 1977 |
Further investigations of the effects of the hypoxic-cell radiosensitizer, Ro-07-0582, on local control of a mouse tumour.
Topics: Animals; Female; Guinea Pigs; Neoplasm Metastasis; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors | 1977 |
Radiosensitizers of hypoxic cells in solid tumors.
Topics: Animals; Cells, Cultured; Cricetinae; Dose-Response Relationship, Drug; Fast Neutrons; Mammary Neoplasms, Experimental; Metronidazole; Mice; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Oxygen Consumption; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1976 |
The effect of an hypoxic cell sensitizer on tumour growth delay and cell survival. Implications for cell survival in situ and in vitro.
Topics: Animals; Cell Survival; Male; Mice; Neoplasm Metastasis; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1975 |
Influence of misonidazole, SR-2508, RSU-1069 and WR-2721 on spontaneous metastases in C57BL mice.
Topics: Amifostine; Animals; Etanidazole; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasm Metastasis; Neoplasms, Experimental; Nitroimidazoles; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1988 |